首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Clinical & Experimental Metastasis

Clinical & Experimental Metastasis杂志,由Springer Netherlands出版,于1983年创刊,Bimonthly,出版语言English,ISSN:0262-0898,E-ISSN:1573-7276。

投稿咨询
Clinical & Experimental Metastasis
Clinical & Experimental Metastasis
Clinical & Experimental Metastasis
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.7
CiteScore
7.4
期刊收录
SCI、SCIE

Clinical & Experimental Metastasis(中文译名:《临床和实验性转移》),ISSN:0262-0898,EISSN:1573-7276,是Springer Netherlands出版的国际性学术期刊,创刊于1983年,以Bimonthly形式稳定发行,2026年总发文量约57篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.7,2025年期刊CiteScore为7.4,2025年期刊自引率约2.7%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Clinical & Experimental Metastasis长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约12月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAGERMANY (FED REP GER)、England、Australia、CHINA MAINLAND、Japan、Spain等为核心发文国家与地区;HELMHOLTZ ASSOCIATIONUNIVERSITY OF TEXAS SYSTEM、RUPRECHT KARLS UNIVERSITY HEIDELBERG、FREE UNIVERSITY OF BERLIN、HUMBOLDT UNIVERSITY OF BERLIN、PETER MACCALLUM CANCER CENTER、UNIVERSITY OF MELBOURNE等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 129 / 333

61.4

学科:ONCOLOGY SCIE Q2 151 / 333

54.8

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 130 / 328

60.5

学科:ONCOLOGY SCIE Q2 140 / 328

57.47


中国学者近期发文

1
All-site radiotherapy for metastatic ewing's sarcoma: a short-term analysis of feasibility, response, and safet

Author:Yang, YuanYou; Xie, Lu; Sun, Xin; Xu, Jie; Ren, Gang

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s10585-026-10406-0

2
LINC01996 suppresses non-small cell lung cancer proliferation and metastasis by orchestrating the miR-12115/CNRIP1/Ras signaling axi

Author:Zhang, Yi; Li, Xiaojing; Liu, Shanshan; Xue, Qian; Meng, Peize; Ge, Xiaolu; Zhao, Qingnan; Ma, Haitao

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 2, pp. -. DOI: 10.1007/s10585-026-10399-w

3
A novel multimodal combining radiomics and tumor-stroma ratio (TSR) improves diagnosis of gastric cancer peritoneal metastasi

Author:Zhong, Lin; Lin, Ting; Hou, Dong; Huang, Hongyun; Zhou, Shihai; Lin, Yu; Yu, Yue; Liu, Liangquan; Luo, Jing; Han, Fanghai; Xie, Lang

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 2, pp. -. DOI: 10.1007/s10585-026-10393-2

4
The clinical trial landscape of colorectal cancer liver metastases: profile analysis and target predictio

Author:Li, Ming; Kai, Jinyan; Xu, Yuchentian; Zhu, Shuai; Chen, Zhijun; Zhao, Huiqing; Zhu, Weixiong

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 1, pp. -. DOI: 10.1007/s10585-026-10392-3

5
Predictive significance of anterior and posterior minimal extrathyroidal extension for central lymph node metastasis in cN0 papillary thyroid carcinom

Author:Zhao, Qi; Zhang, Yuyang; Hua, Rui; Lv, Bin; Liu, Nan

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2026; Vol. 43, Issue 1, pp. -. DOI: 10.1007/s10585-025-10388-5

6
Oligo-residual disease in metastatic ALK-positive NSCLC treated with alectini

Author:Yang, Xi; Chu, Xiao; Ye, Ruiting; Ni, Jianjiao; Zeng, Ya; Zhou, Yue; Xia, Qing; Wang, Shengping; Li, Qiao; Liu, Shuai; Zhu, Zhengfei; Chu, Li

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 4, pp. -. DOI: 10.1007/s10585-025-10351-4

7
Deep learning MRI-based radiomic models for predicting recurrence in locally advanced nasopharyngeal carcinoma after neoadjuvant chemoradiotherapy: a multi-center stud

Author:Hu, Chunmiao; Xu, Congrui; Chen, Jiaxin; Huang, Yiling; Meng, Qingcheng; Lin, Zhian; Huang, Xinming; Chen, Li

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10349-y

8
Interplay of GPC3, Hsa-miR-135b-3p, and FTLP3 in lung cancer metastasi

Author:Yang, Lijun; Li, Jiping

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10340-7

9
TEAD4 promoted proliferation and metastasis of gallbladder cancer by regulation of TMPRSS

Author:Lin, Conglin; Wang, Congren; Li, Mingzhu; Cai, Zhibing

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10339-0

10
Ras-proximate-1 (RAP1): a prognosis and therapeutic target in the metastatic spread of breast cance

Author:Liang, Hongyi; Yin, Guoliang; Feng, Dandan; Shi, Guangxi; Chen, Hanhan; Liu, Xiaofei; Li, Jingwei

Journal: CLINICAL & EXPERIMENTAL METASTASIS. 2025; Vol. 42, Issue 3, pp. -. DOI: 10.1007/s10585-025-10342-5


在线咨询

Clinical & Experimental Metastasis

国际简称:CLIN EXP METASTAS参考译名:临床和实验性转移

年发文量:57 CiteScore:7.4 是否预警:否 Gold OA文章占比:46.75% 研究类文章占比:75.44%

杂志社联系方式:SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ

Clinical & Experimental Metastasis